MIRA PHARMACEUTICALS INC (MIRA) Stock Balance Sheet
USA - NASDAQ:MIRA - US60458C1045 - Common Stock
1.41 USD
+0.05 (+3.68%)
1.38 USD
-0.03 (-2.13%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 730.50K | 2.83M | 4.60M | 351.00K | 2.81M | |||
| Cash Equivalents | null | null | null | null | null | |||
| Cash Due From Banks | null | null | null | null | null | |||
| Investments | null | null | null | null | null | |||
| Net Loans | null | null | null | null | null | |||
| Insurance Receivables | null | null | null | null | null | |||
| Marketable Securities | null | null | null | null | null | |||
| Receivables | null | null | 11.90K | null | null | |||
| Inventories | null | null | null | null | null | |||
| Other Current Assets | 102.40K | 54.70K | 243.80K | 143.40K | 100.00K | |||
| Total Current Assets | 832.90K | 2.89M | 4.86M | 494.40K | 2.91M | |||
| Non-Current Assets | ||||||||
| PPE Net | null | 0 | 5.10K | 363.70K | null | |||
| Investments And Advances | null | null | null | null | null | |||
| Goodwill | null | null | null | null | null | |||
| Intangibles | null | null | null | null | null | |||
| Other Non-Current Assets | null | null | null | null | null | |||
| Total Non-Current Assets | 35.40K | 35.40K | 74.20K | 363.70K | 445.60K | |||
| TOTAL ASSETS | 868.30K | 2.92M | 4.93M | 858.10K | 3.36M | |||
| LIABILITIES | ||||||||
| Total Deposits | null | null | null | null | null | |||
| Current Liabilities | ||||||||
| Short Term Borrowings | null | null | null | null | null | |||
| Short Term Debt | 0 | 0 | 0 | 133.10K | 293.10K | |||
| Current Portion Of LT Debt. | null | null | null | null | null | |||
| Accrued Expenses | 0 | null | 19.50K | 308.90K | 24.70K | |||
| Accounts Payable | 298.50K | 723.40K | 538.60K | 811.70K | 228.40K | |||
| Other Current Liabilities | null | null | 0 | 116.40K | 547.60K | |||
| Total Current Liabilities | 298.50K | 723.40K | 558.10K | 1.37M | 1.09M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0 | 0 | 0 | 0 | 0 | |||
| Deferred Taxes/Income | null | null | null | null | null | |||
| Other Non-Current Liabilities | null | null | 0 | 84.30K | null | |||
| Total Non-Current Liabilities | 0 | 0 | 0 | 84.30K | 0 | |||
| TOTAL LIABILITIES | 298.50K | 723.40K | 558.10K | 1.45M | 1.09M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -32.46M | -29.14M | -21.29M | -9.30M | -2.24M | |||
| Additional Paid In Capital | 33.03M | 31.34M | 25.66M | 8.70M | 4.50M | |||
| Minority Interest | null | null | null | null | null | |||
| Common Shares | 1.70K | 1.70K | 1.50K | 6.70K | 6.30K | |||
| Treasury Stock | null | null | null | null | null | |||
| Other Shareholders' Equity | null | null | null | null | 0 | |||
| Shares Outstanding | 17.39M | 16.56M | 14.78M | 14.75M | 14.75M | |||
| Tangible Book Value per Share | 0.0328 | 0.1328 | 0.296 | -0.0404 | 0.1534 | |||
| Total Shareholders' Equity | 569.90K | 2.20M | 4.37M | -596.20K | 2.26M | |||
| TOTAL LIABILITIES AND EQUITY | 868.30K | 2.92M | 4.93M | 858.10K | 3.36M | |||
| Statistics | ||||||||
| Current Ratio | 2.79 | 3.99 | 8.70 | 0.36 | 2.66 | |||
| Return On Assets (ROA) | -894.29% | -268.64% | -242.93% | -822.54% | -64.87% | |||
| Return On Equity (ROE) | -1362.54% | -356.97% | -273.92% | N/A | -96.25% | |||
All data in USD , ROIC based on taxRate of 0.21